期刊文献+

Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy 被引量:3

下载PDF
导出
摘要 We encapsulated vincristine into folic acid-conjugated PEGylated liposomes to improve the anti-tumor efficacy on multidrug resistant cancers.It was observed that the drug delivery system we constructed exhibited maximum cytotoxicity on KBv200 cells(multidrug resistant variant)compared with any other formulations.The semi-quantitative analysis of region of interest revealed that there was a great increase in area under curve(AUC)of a near-infrared fluorescein in solid tumors due to folic acid-mediated accumulation.Folic acid-conjugated PEGylated liposomes showed a significant tumor growth inhibiting effect in vitro and in vivo.TUNEL assay revealed that folic acid-conjugated PEGylated liposomes could induce cell apoptosis much more greatly than others.This study demonstrated that it had potential application prospective for the treatment of multidrug resistant cancer.
出处 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2013年第2期118-127,共10页 亚洲药物制剂科学(英文)
基金 This work was supported by National Science and Technology Major Project(2012ZX09304004) National Basic Research Program of China(973 Program,2010CB934000) National Natural Science Foundation of China(81072593,81102402) Specialized Research Fund for the Doctoral Program of Higher Education(20110071130011).
  • 相关文献

参考文献2

二级参考文献1

  • 1Shen D W,J Biol Chem,1986年,261卷,7762页

共引文献74

同被引文献42

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部